Arvind Dasari, MD, MS, The University of Texas MD Anderson Cancer Center, Houston, TX, outlines the use of ctDNA in the management of patients with colorectal cancer (CRC), including the prognostic value of ctDNA as well as its use in minimal residual disease detection. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).